Stay updated on Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial page.

Latest updates to the Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference3%

- Check36 days agoChange DetectedUpdated to Revision: v3.1.0 and removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while keeping the revision label as the primary addition.SummaryDifference0.4%

- Check50 days agoChange DetectedUpdated to v3.0.2 and removed the Back to Top link; core content remains unchanged.SummaryDifference0.2%

- Check57 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%

- Check65 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new drug information, locations, and a detailed study reference, while also removing some previous location and drug information. Notably, the facility name and various drug safety details have been included.SummaryDifference14%

- Check79 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial page.